FDA — authorised 29 February 1988
- Marketing authorisation holder: MERZ PHARMS
- Status: approved
🇺🇸 Naftin in United States
FDA authorised Naftin on 29 February 1988
Marketing authorisations
FDA — authorised 29 February 1988
- Application: NDA019599
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: NAFTIN
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 18 June 1990
- Application: NDA019356
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: NAFTIN
- Indication: GEL — TOPICAL
- Status: approved
Naftin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Naftin approved in United States?
Yes. FDA authorised it on 29 February 1988; FDA authorised it on 29 February 1988; FDA authorised it on 18 June 1990.
Who is the marketing authorisation holder for Naftin in United States?
MERZ PHARMS holds the US marketing authorisation.